Loading company…
Nanoqure Biotech develops antimicrobial peptides targeting bacteria resistant to traditional drugs.
Nanoqure Biotech develops antimicrobial drugs, including a broad-spectrum peptide intended to target multidrug-resistant bacteria. Its core technical team comes from Harvard Medical School in the United States. Founded in 2024, the company is based in Jinan, China. In October 2024, it received venture funding from Finnova Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in